The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Insulin-like growth factors and cancer
Open accessAbstract
The insulin-like growth factors (IGFs). also known as somatomedins, have been identified as a result of three separate lines of research carried out over the last 30 years (Van Wyk & Underwood, 1978). First, IGFs promote incorporation of 35-sulphate into cartilage, hence 'sulphation' factor (Salmon & Daughaday, 1957). Secondly, they mediate the mitogenic activity of serum (Pierson & Temin, 1972) and medium conditioned by rat hepatocytes (multiplication stimulating activity, MSA; Dulak & Temin. 1973). Thirdy. IGFs have insulin-like activity which is not inhibited by anti-insulin antibodies (non-suppressive insulin-like activity, NSILA: Froesch et al., 1963). Sequence analysis revealed that these functions are subserved by two main peptide: IGF-I, also known as somatomedin-C (Klapper et al.. 1983) and IGF-II. of which the rat form is MSA (Rinderknecht & Humbel. 1978; Marquardt et al.. 1981). The IGF terminology is now preferred as there is no somatomedin designation for IGF-II (Daughaday et al.. 1987). IGF-I (70 residues, MW 7649) and IGF-II (67 residues. MW 7471) are single chain peptides with around 70% sequence homology, and 50% homology with pro-insulin. Mature IGFs have A and B domains where the homology with proinsulin is highest, a C-peptide domain which has no sequence homology with proinsulin. and a carboxyterminal D domain (Daughaday & Rotwein. 1989). The IGF-I gene is located on chromosome 12q, and the IGF-II gene is on chromosome llp, contiguous with the insulin gene (Barreca & Minuto. 1989). In the mouse, the IGF-II gene is imprinted. that is. there is a difference in expression between the maternal and paternal genes. Specifically, it is the paternal IGF-II gene which is active (Willison. 1991). IGF-I is synthesised by the liver and also by other viscera including kidney and lung (D'Ercole et al., 1984). Hepatic synthesis, which largely determines serum levels, is regulated by growth hormone (GH) and also varies with liver function and nutritional status (Underwood et al., 1986; Zapf & Froesch. 1986). In endocrine-sensitive tissues. IGF-I gene expression may be regulated by hormones other than GH. Notably in rat uterus, IGF-I expression is enhanced by oestrogen, and is repressed to a small extent by GH (Murphy & Friesen, 1988). In vitro, IGF-I is a potent mitogen for normal cells including chondrocytes and other mesenchymal derivatives (Clemmons & Van Wyk, 1981). In vivo, IGF-I has acute insulin-like anabolic effects on adipose tissue, muscle and liver (Zapf & Froesch, 1986; Guler et al.. 1987). However its most important physiological role is as the primary regulator of growth, especially of mesenchymal tissues including bone and cartilage (Schoenle et al., 1982; Van Buul-Offers et al.. 1986; Mathews et al., 1988). IGF-II has metabolic and mitogenic effects experimentally, but its physiological function is unclear. Serum concentrations are less dependent on GH. and it causes less growth promotion in hypophysectomised animals (Schoenle et al., 1983). IGF-II mRNA is expressed in foetal tissues of mesenchymal origin, including kidney, liver
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., & Chen, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04528.x · Cited by 1,844
DAUGHADAY, W. H., & ROTWEIN, P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-1-68 · Cited by 1,725
Autocrine Secretion and Malignant Transformation of Cells
Sporn, M. B., & Todaro, G. J. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031511 · Cited by 1,346
D'Ercole, A. J., Stiles, A. D., & Underwood, L. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.935 · Cited by 1,186
Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., & Binoux, M. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90507-5 · Cited by 1,143
A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
SALMON, W. D., & Daughaday, W. H. (1957) · PubMed · Cited by 1,084
Insulin‐like growth factors I and II
HUMBEL, R. E. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15595.x · Cited by 999
Insulin-like growth factor II receptor as a multifunctional binding protein
Morgan, D. O., Edman, J. C., Standring, D. N., Fried, V. A., Smith, M. C., Roth, R. A., & Rutter, W. J. (1987) · Nature · doi:10.1038/329301a0 · Cited by 853
Treatment of the Malignant Carcinoid Syndrome
Kvols, L. K., Moertel, C. G., O'Connell, M. J., Schutt, A. J., Rubin, J., & Hahn, R. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151102 · Cited by 849
Primary structure of human insulin‐like growth factor II
Rinderknecht, E., & Humbel, R. E. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)80237-3 · Cited by 780
Cited by
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
Giovannucci, E. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3109s · Cited by 959
Giovannucci, E. (1995) · Cancer Causes and Control · doi:10.1007/bf00052777 · Cited by 817
Calle, E. E., & Thun, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207751 · Cited by 769
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
The Insulin-Like Growth Factors
Cohick, W. S., & Clemmons, D. R. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.001023 · Cited by 638
Inoue, M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1871 · Cited by 561
Calorie Restriction, Aging, and Cancer Prevention: Mechanisms of Action and Applicability to Humans
Hursting, S. D., Lavigne, J. A., Berrigan, D., Perkins, S. N., & Barrett, J. C. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152156 · Cited by 556
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., & Baserga, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11217 · Cited by 553
Giovannucci, E., & Michaud, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.050 · Cited by 543
Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., & Baserga, R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3604 · Cited by 538
Al-Nasiry, S., Geusens, N., Hanssens, M., Luyten, C., & Pijnenborg, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem011 · Cited by 486
The IGF-I receptor in cell growth, transformation and apoptosis
Baserga, R., Hongo, A., Rubini, M., Prisco, M., & Valentinis, B. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00007-3 · Cited by 439
Nutrition, hormones, and breast cancer: Is insulin the missing link?
Kaaks, R. (1996) · Cancer Causes and Control · doi:10.1007/bf00051703 · Cited by 360
Diabetes mellitus and risk of prostate cancer: a meta-analysis
Bonovas, S., Filioussi, K., & Tsantes, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1415-6 · Cited by 327
Insulin-like Growth Factors and Cancer
LeRoith, D., Baserga, R., Helman, L., & Roberts Jr., C. T. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00009 · Cited by 317
Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine
Nimptsch, K., Konigorski, S., & Pischon, T. (2019) · Metabolism · doi:10.1016/j.metabol.2018.12.006 · Cited by 314
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis
Wang, P., Kang, D., Cao, W., Wang, Y., & Liu, Z. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1291 · Cited by 310
van den Boom, J., Wolter, M., Kuick, R., Misek, D. E., Youkilis, A. S., Wechsler, D. S., Sommer, C., Reifenberger, G., & Hanash, S. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63463-3 · Cited by 307
Diabetes mellitus and risk of bladder cancer: a meta-analysis
Larsson, S. C., Orsini, N., Brismar, K., & Wolk, A. (2006) · Diabetologia · doi:10.1007/s00125-006-0468-0 · Cited by 304
The IGF-I Receptor in Cancer Research
Baserga, R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4667 · Cited by 292
Obesity and breast cancer: a review of the literature
Carmichael, A. R., & Bates, T. (2004) · The Breast · doi:10.1016/j.breast.2003.03.001 · Cited by 291
Warren, R. S., Yuan, H., Matli, M. R., Ferrara, N., & Donner, D. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29483 · Cited by 274
The association of breast mitogens with mammographic densities
Boyd, N. F., Stone, J., Martin, L. J., Jong, R., Fishell, E., Yaffe, M., Hammond, G., & Minkin, S. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600537 · Cited by 272
Fabian, C. J., Kimler, B. F., Zalles, C. M., Klemp, J. R., Kamel, S., Zeiger, S., & Mayo, M. S. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1217 · Cited by 272
Lopez, T., & Hanahan, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00055-7 · Cited by 268
Aberrant Signaling Pathways in Glioma
Nakada, M., Kita, D., Watanabe, T., Hayashi, Y., Teng, L., Pyko, I. V., & Hamada, J.-I. (2011) · Cancers · doi:10.3390/cancers3033242 · Cited by 264
Do insulin-like growth factors mediate the effect of alcohol on breast cancer risk?
Yu, H., & Berkel, J. (1999) · Medical Hypotheses · doi:10.1054/mehy.1998.0828 · Cited by 31
Metadata
- Authors
- Macaulay, V.
- Venue
- British Journal of Cancer
- Published
- 1992-03
- Volume
- 65
- Issue
- 3
- Pages
- 311-320
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2056854271
- Cited by
- 601
- References
- 98
- FWCI
- 18.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.